- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | VITURA HEALTH LIMITED: Notification of cessation of securities - VIT | 1 | ASX | ||
| 28.01. | VITURA HEALTH LIMITED: CEO Transition and Interim Leadership Update | - | ASX | ||
| 11.01. | VITURA HEALTH LIMITED: Notification of cessation of securities - VIT | - | ASX | ||
| 09.01. | VITURA HEALTH LIMITED: Appointment of Chief Financial Officer | 3 | ASX | ||
| 05.01. | VITURA HEALTH LIMITED: Amended Constitution - Late Lodgement | - | ASX | ||
| VITURA HEALTH Aktie jetzt für 0€ handeln | |||||
| 05.01. | VITURA HEALTH LIMITED: Notification of cessation of securities - VIT | - | ASX | ||
| 23.12.25 | VITURA HEALTH LIMITED: Change of Director's Interest Notice - Late Lodgement | 1 | ASX | ||
| 17.12.25 | VITURA HEALTH LIMITED: Change of Company Secretary | - | ASX | ||
| 01.12.25 | VITURA HEALTH LIMITED: Industry Advisory Group Charter | 2 | ASX | ||
| 26.11.25 | VITURA HEALTH LIMITED: Results of 2025 Annual General Meeting | 1 | ASX | ||
| 25.11.25 | VITURA HEALTH LIMITED: 2025 AGM presentation | - | ASX | ||
| 25.11.25 | VITURA HEALTH LIMITED: Withdrawal of resolution | 1 | ASX | ||
| 28.10.25 | VITURA HEALTH LIMITED: Ceasing to be a substantial holder | - | ASX | ||
| 27.10.25 | VITURA HEALTH LIMITED: Resignation of CFO and Company Secretary | 2 | ASX | ||
| 22.10.25 | VITURA HEALTH LIMITED: Notice of 2025 Annual General Meeting | - | ASX | ||
| 22.10.25 | VITURA HEALTH LIMITED: 2025 Annual Report | - | ASX | ||
| 01.10.25 | VITURA HEALTH LIMITED: Application for quotation of securities - VIT | 1 | ASX | ||
| 25.09.25 | VITURA HEALTH LIMITED: Update - Dividend/Distribution - VIT | - | ASX | ||
| 25.09.25 | VITURA HEALTH LIMITED: DRP allocation price | - | ASX | ||
| 24.09.25 | VITURA HEALTH LIMITED: Date for 2025 AGM | - | ASX |
1 2 Weiter >>
32 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| AURORA CANNABIS | 2,925 | -0,85 % | Aurora Cannabis Inc.: Aurora Cannabis Announces Fiscal 2026 Third Quarter Results | NASDAQ | TSX: ACB
Expands YoY Total Net Revenue1 by 7% to $94.2 million, with Global Medical Cannabis Net Revenue1 Increasing by 12% to a Record $76.2 million
... ► Artikel lesen | |
| TILRAY BRANDS | 6,450 | +0,62 % | Tilray Brands, Inc.: CC Pharma von Tilray als eines der 100 innovativsten Unternehmen in Deutschland ausgezeichnet | Die Auszeichnung würdigt CC Pharma als innovativen Marktführer und vertrauenswürdigen Partner auf dem europäischen PharmamarktDENSBORN, Deutschland, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Tilray Pharma,... ► Artikel lesen | |
| ORGANIGRAM GLOBAL | 1,250 | -4,58 % | Organigram Global Inc: Organigram to release fiscal Q1 results Feb. 10 | ||
| SNDL | 1,254 | -2,18 % | 1CM Inc.: SNDL & 1CM Complete Purchase and Sale of 5 Retail Stores in Alberta and Saskatchewan | Edmonton, Alberta and Toronto, Ontario--(Newsfile Corp. - January 7, 2026) - SNDL Inc. (NASDAQ: SNDL) (CSE: SNDL) ("SNDL") and 1CM Inc. (CSE: EPIC) (OTCQB: MILFF) (FSE: IQ70) ("1CM") are pleased... ► Artikel lesen | |
| NOVERIS HEALTH SCIENCES | 0,155 | 0,00 % | XFRA CAPITAL ADJUSTMENT INFORMATION - 03.02.2026 | Das Instrument 0NF CA62849F4087 MYDECINE INNOVAT.GRP NEW EQUITY wird cum Kapitalmassnahme gehandelt am 03.02.2026 und ex Kapitalmassnahme am 04.02.2026 The instrument 0NF CA62849F4087 MYDECINE INNOVAT.GRP... ► Artikel lesen | |
| BIONANO GENOMICS | 1,155 | +2,67 % | Bionano Genomics: Bionano Reports Third Quarter 2025 Results and Highlights Recent Business Progress | SAN DIEGO, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the third quarter ended September 30, 2025. "Over the last year, we have taken... ► Artikel lesen | |
| TONIX PHARMACEUTICALS | 13,400 | -3,60 % | Tonix Pharmaceuticals Holding Corp. - 8-K, Current Report | ||
| HIGH TIDE | 1,970 | 0,00 % | Is High Tide stock still a buy? | ||
| ACHIEVE LIFE SCIENCES | 3,385 | -5,97 % | Achieve Life Sciences: Entscheidet der 20. Juni über Leben und Tod? | Seit unseres Trading-Tipps im Juli letzten Jahres konnte die Aktie von Achieve Life Sciences zwischenzeitlich über +150% zulegen, korrigierte in den letzten Wochen aber wieder um mehr als 20%. Das Unternehmen... ► Artikel lesen | |
| JAGUAR HEALTH | 0,670 | +13,47 % | Jaguar Health, Inc.: Jaguar Health Highlights Sharp Strategic Focus on Rare Intestinal Failure Diseases Fueled by Non-Dilutive Funds from Closing of License Deal for Mytesi | Jaguar has received the initial $16M payment related to the company's recently executed US out-license agreement for Mytesi and Canalevia-CA1, which has the potential to provide Jaguar up to an additional... ► Artikel lesen | |
| MEDIPHARM LABS | 0,039 | 0,00 % | MediPharm Labs Corp.: MediPharm Labs Announces CEO Transition: David Pidduck to Step Down; CFO Greg Hunter Appointed Interim CEO | TORONTO, Jan. 19, 2026 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm" or the "Company"), a pharmaceutical company specialized in precision-based cannabinoids... ► Artikel lesen | |
| ARGENT BIOPHARMA | 0,038 | +19,05 % | Argent BioPharma Ltd.: Argent is Growing Through M&A: Projected Merged Company Value of $100M in AC8 Asset Acquisition | Acquisition Expands Clinical Pipeline, Strengthens IP Portfolio, and Grows EU Presence
Highlights
Binding term sheet signed to acquire key assets and IP of AusCann... ► Artikel lesen | |
| AUSCANN | - | - | Argent BioPharma Signs $15m Deal to Acquire Key Clinical and IP Assets from AusCann | ||
| AYR WELLNESS | 0,040 | 0,00 % | CSE Bulletin: Expiry - Ayr Wellness Inc. 7FEB2026 Warrants (AYR.WT.U) | Toronto, Ontario--(Newsfile Corp. - Le 3 février/February 2026) - Ayr Wellness Inc. 7FEB2026 Warrants listed on February 14, 2024 with an expiry date of February 7, 2026 will expire on February... ► Artikel lesen |
VITURA HEALTH LIMITED gehört der Branche Pharma an. Die relative Kursveränderung beträgt aktuell -7,41 % bei einem Aktienkurs von 0,025 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu VITURA HEALTH LIMITED finden Sie auf Wallstreet Online.